Prescribing information


Please contact a Novartis representative to order these materials.

Rate this content: 
Average: 5 (1 vote)
XSU20-C024(1) November 2020.

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]